Zachary Roberts
Net worth: 418 923 $ as of 30/05/2026
Net worth: 418 923 $ as of 30/05/2026
Zachary Roberts currently works at Allogene Therapeutics, Inc., as Chief Medical Officer & Executive Vice President from 2023.
Dr. Roberts also formerly worked at Amgen, Inc., as Director-Clinical Medical Research in 2015, Instil Bio, Inc., as Chief Medical Officer from 2020 to 2022, and Kite Pharma, Inc., as Vice President-Clinical Development from 2018 to 2019.
Dr. Roberts received his undergraduate degree from the University of Maryland and doctorate degree from the University of Maryland School of Medicine.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/03/2026 | 193,052 ( 0.06% ) | 418 923 $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 02/01/2023 |
| Companies | Position | End |
|---|---|---|
| INSTIL BIO, INC. | Chief Tech/Sci/R&D Officer | 10/11/2022 |
| KITE PHARMA INC | Chief Tech/Sci/R&D Officer | 30/04/2019 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 30/06/2015 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland School of Medicine
University of Maryland School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Instil Bio, Inc.
Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
Select your edition
All financial news and data tailored to specific country editions